United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - almotriptan tablets (almotriptan malate) are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. almotriptan tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan tablets, the diagnosis of migraine should be reconsidered before almotriptan tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine [see contraindications (4.7)] . safety and ef

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - adults almotriptan malate tablets are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. adolescents age 12 to 17 years almotriptan malate tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan malate tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan malate tablets, the diagnosis of migraine should be reconsidered before almotriptan malate tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan malate tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan malate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic

United States - English - NLM (National Library of Medicine)

ajanta pharma usa inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - adults almotriptan tablets, usp are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. adolescents age 12 to 17 years almotriptan tablets, usp are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan tablets, the diagnosis of migraine should be reconsidered before almotriptan tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine [see contraindicat

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - almotriptan hydrogen malate - oral tablet - 12.5mg

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle medical - almotriptan malate - film coated tablet - 12.5 milligram - almotriptan

Canada - English - Health Canada

apotex inc - almotriptan (almotriptan malate) - tablet - 6.25mg - almotriptan (almotriptan malate) 6.25mg - selective serotonin agonists

Canada - English - Health Canada

apotex inc - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists

Canada - English - Health Canada

pro doc limitee - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists

Canada - English - Health Canada

sanis health inc - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists

United States - English - NLM (National Library of Medicine)

patriot pharmaceuticals, llc - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg